233 related articles for article (PubMed ID: 33450501)
1. Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study.
Elser HC; Koch-Henriksen N; Magyari M
Mult Scler Relat Disord; 2021 Apr; 49():102739. PubMed ID: 33450501
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Villaverde-González R; Candeliere-Merlicco A; Alonso-Frías MA; Aparicio Castro E; Carrillo Alcaraz A; Mallada Frechín J; Pérez Sempere Á
Mult Scler Relat Disord; 2020 Nov; 46():102518. PubMed ID: 32977075
[TBL] [Abstract][Full Text] [Related]
3. Worsening of disability caused by relapses in multiple sclerosis: A different approach.
Koch-Henriksen N; Thygesen LC; Sørensen PS; Magyari M
Mult Scler Relat Disord; 2019 Jul; 32():1-8. PubMed ID: 31003200
[TBL] [Abstract][Full Text] [Related]
4. Relapses add to permanent disability in relapsing multiple sclerosis patients.
Koch-Henriksen N; Sørensen PS; Magyari M
Mult Scler Relat Disord; 2021 Aug; 53():103029. PubMed ID: 34116481
[TBL] [Abstract][Full Text] [Related]
5. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC
Brain; 2010 Jul; 133(Pt 7):1914-29. PubMed ID: 20534650
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and disease activity in Danish women with multiple sclerosis: A population-based cohort study.
Kopp TI; Lidegaard Ø; Magyari M
Eur J Neurol; 2022 Jun; 29(6):1753-1762. PubMed ID: 35196406
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Foo EC; Russell M; Lily O; Ford HL
Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
[TBL] [Abstract][Full Text] [Related]
9. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
Tremlett H; van der Mei IA; Pittas F; Blizzard L; Paley G; Mesaros D; Woodbaker R; Nunez M; Dwyer T; Taylor BV; Ponsonby AL
Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
[TBL] [Abstract][Full Text] [Related]
10. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
[TBL] [Abstract][Full Text] [Related]
11. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy in Multiple Sclerosis: A Portuguese cohort study.
Jesus-Ribeiro J; Correia I; Martins AI; Fonseca M; Marques I; Batista S; Nunes C; Macário C; Almeida MC; Sousa L
Mult Scler Relat Disord; 2017 Oct; 17():63-68. PubMed ID: 29055477
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis in the elderly: a retrospective cohort study.
Zinganell A; Göbel G; Berek K; Hofer B; Asenbaum-Nan S; Barang M; Böck K; Bsteh C; Bsteh G; Eger S; Eggers C; Fertl E; Joldic D; Khalil M; Langenscheidt D; Komposch M; Kornek B; Kraus J; Krendl R; Rauschka H; Sellner J; Auer M; Hegen H; Pauli FD; Deisenhammer F
J Neurol; 2024 Feb; 271(2):674-687. PubMed ID: 37855871
[TBL] [Abstract][Full Text] [Related]
14. Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study.
Papathanasiou A; Hibbert A; Tallantyre E; Harding K; Selvam AP; Morgan M; Quainton C; Talaei M; Arun T; Ingram G; Law GR; Evangelou N
Neurol Sci; 2023 Oct; 44(10):3629-3635. PubMed ID: 37208584
[TBL] [Abstract][Full Text] [Related]
15. How patients with multiple sclerosis acquire disability.
Lublin FD; Häring DA; Ganjgahi H; Ocampo A; Hatami F; Čuklina J; Aarden P; Dahlke F; Arnold DL; Wiendl H; Chitnis T; Nichols TE; Kieseier BC; Bermel RA
Brain; 2022 Sep; 145(9):3147-3161. PubMed ID: 35104840
[TBL] [Abstract][Full Text] [Related]
16. Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.
Correia I; Ribeiro JJ; Isidoro L; Batista S; Nunes C; Macário C; Borges C; Tomaz J; Sousa L
Mult Scler Relat Disord; 2018 Jan; 19():148-152. PubMed ID: 29241141
[TBL] [Abstract][Full Text] [Related]
17. [Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients].
Le Page E; Leray E; Taurin G; Coustans M; Chaperon J; Edan G
Rev Neurol (Paris); 2006 Feb; 162(2):185-94. PubMed ID: 16518258
[TBL] [Abstract][Full Text] [Related]
18. Predictors of relapse rate in MS clinical trials.
Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
[TBL] [Abstract][Full Text] [Related]
19. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark.
Stastna D; Elberling F; Pontieri L; Framke E; Horakova D; Drahota J; Nytrova P; Magyari M
Eur J Neurol; 2024 Mar; 31(3):e16163. PubMed ID: 38015454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
